BBA
BNR

Baker Bros. Advisors’s Burning Rock Biotech BNR Stock Holding History

Baker Bros. Advisors’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,913
Closed -$609K – 117
2022
Q2 		$609K Hold
20,913
– – ﹤0.01% 107
2022
Q1 		$1.94M Hold
20,913
– – 0.01% 101
2021
Q4 		$1.99M Hold
20,913
– – 0.01% 107
2021
Q3 		$3.74M Hold
20,913
– – 0.02% 105
2021
Q2 		$6.16M Hold
20,913
– – 0.03% 91
2021
Q1 		$5.63M Hold
20,913
– – 0.02% 88
2020
Q4 		$4.83M Sell
20,913
-2,817
-12% -$756K 0.02% 93
2020
Q3 		$5.95M Sell
23,730
-1,270
-5% -$301K 0.02% 78
2020
Q2 		$6.75M Buy
+25,000
New +$6.85M 0.03% 75

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Baker Bros. Advisors's BNR Position: Q3 2022 in Review

Baker Bros. Advisors sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 20,913 shares — an estimated $609K sold.

Baker Bros. Advisors first reported a position in BNR in Q2 2020 and held it in 9 quarters. The position peaked at $6.75M in Q2 2020. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • Baker Bros. Advisors reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • Baker Bros. Advisors sold 20,913 Burning Rock Biotech shares in Q3 2022, an estimated $609K.
  • Baker Bros. Advisors first reported a position in Burning Rock Biotech in Q2 2020 and held it in 9 quarters.
  • Baker Bros. Advisors's Burning Rock Biotech position peaked at $6.75M in Q2 2020.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on Baker Bros. Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.